Evidence map›Paper›PMID 23105095›Full record

ArticleThe Journal of biological chemistry2013

Liver retinol transporter and receptor for serum retinol-binding protein (RBP4).

Philomena Alapatt, Fangjian Guo, Susan M Komanetsky, Shuping Wang, Jinjin Cai, Ashot Sargsyan, Eduardo Rodríguez Díaz, Brandon T Bacon, Pratik Aryal, Timothy E Graham

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Review
  3. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Amino acid insufficiency impairs hepatic vitamin A mobilization in mice.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Advances and therapeutic opportunities in visual cycle modulation.Progress in retinal and eye research · 2025
    Review
  14. Article
  15. Loss of the vitamin A receptor RBPR2 in mice disrupts whole-body retinoid homeostasis and the quantitative balance regulating retinylidene protein synthesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  16. Article
  17. Signaling via retinoic acid receptors mediates decidual angiogenesis in mice and human stromal cell decidualization.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  18. Immunometabolic effects ofImmunometabolism (Cobham, Surrey) · 2024
    Review
  19. Review
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Philomena AlapattMolecular Medicine Program and Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Utah, Salt Lake City, Utah 84112, USA.
Fangjian Guo
Susan M Komanetsky
Shuping Wang
Jinjin Cai
Ashot Sargsyan
Eduardo Rodríguez Díaz
Brandon T Bacon
Pratik Aryal
Timothy E Graham
University of Utah · USHarvard University Press · US

Funding

RBP4-Transthyretin Interactions in Insulin Resistant StatesR03DK080195 · NIDDK · UNIVERSITY OF UTAH · PI GRAHAM, TIMOTHY E. · 2008 to 2009
$160k
Tissue specific production of RBP4 and mechanism of insulin resistanceI01BX000937 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI GRAHAM, TIMOTHY E. · 2011 to 2013
–
BLRD VA I01 BX000937Howard Hughes Medical InstituteNIDDK NIH HHS R03 DK080195
6 · The paper itself

Abstract

Vitamin A (retinol) is absorbed in the small intestine, stored in liver, and secreted into circulation bound to serum retinol-binding protein (RBP4). Circulating retinol may be taken up by extrahepatic tissues or recycled back to liver multiple times before it is finally metabolized or degraded. Liver exhibits high affinity binding sites for RBP4, but specific receptors have not been identified. The only known high affinity receptor for RBP4, Stra6, is not expressed in the liver. Here we report discovery of RBP4 receptor-2 (RBPR2), a novel retinol transporter expressed primarily in liver and intestine and induced in adipose tissue of obese mice. RBPR2 is structurally related to Stra6 and highly conserved in vertebrates, including humans. Expression of RBPR2 in cultured cells confers high affinity RBP4 binding and retinol transport, and RBPR2 knockdown reduces RBP4 binding/retinol transport. RBPR2 expression is suppressed by retinol and retinoic acid and correlates inversely with liver retinol stores in vivo. We conclude that RBPR2 is a novel retinol transporter that potentially regulates retinol homeostasis in liver and other tissues. In addition, expression of RBPR2 in liver and fat suggests a possible role in mediating established metabolic actions of RBP4 in those tissues.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCarrier ProteinsCell LineCloning, MolecularDNA PrimersHumansLiverMembrane ProteinsMiceMice, Inbred C57BLMolecular Sequence DataPolymerase Chain ReactionPromoter Regions, GeneticRetinol-Binding Proteins, PlasmaCarrier ProteinsDNA PrimersMembrane ProteinsRBP4 protein, humanRbp4 protein, mouseRetinol-Binding Proteins, PlasmaStra6 protein, mouse

Identifiers

PMID23105095
PMCPMC3543007
OpenAlexW2060140841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.